June 19, 2019 / 11:03 AM / 6 months ago

BUZZ-Trial data on Ironwood, Allergan's constipation drug to boost prescriptions - CS

** Ironwood Pharmaceuticals Inc and Allergan Plc said on Tuesday their constipation drug Linzess improved abdominal symptoms of bloating, pain and discomfort in patients suffering from irritable bowel syndrome with constipation

** Expect an uptick in Linzess prescription in the coming months, although magnitude is unclear - Credit Suisse analyst Vamil Divan

** Cos say 4.6% of patients reported diarrhea in the trial, which Divan says is much lower than the 20% incident rate mentioned in the product label

** Ironwood has said it should be able to promote these new claims immediately and not need to have to wait for an updated product label - Divan

** Divan believes lower net price will continue to impact sales of the drug

** Linzess, sold jointly in the United States by IRWD and AGN, brought in sales of $161.3 mln in Q1 for AGN; IRWD received $64.3 million in Q1 from U.S. sales of Linzess

** IRWD had risen ~32% YTD, while AGN had fallen 9.7% (Reporting by Manas Mishra in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below